Highlander Partners’s Mirum Pharmaceuticals MIRM Stock Holding History

Highlander Partners’s Portfolio MIRM Stock Details MIRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$11.4M	Hold	122,980	–	–	4.45%	7
2025 Q4	$9.71M	Hold	122,980	–	–	3.49%	12
2025 Q3	$9.02M	Hold	122,980	–	–	3.14%	13
2025 Q2	$6.26M	Hold	122,980	–	–	2.4%	15
2025 Q1	$5.54M	Hold	122,980	–	–	3.43%	10
2024 Q4	$5.09M	Hold	122,980	–	–	2.89%	10
2024 Q3	$4.8M	Hold	122,980	–	–	2.83%	11
2024 Q2	$4.2M	Hold	122,980	–	–	2.8%	12
2024 Q1	$3.09M	Hold	122,980	–	–	2.14%	14
2023 Q4	$3.63M	Hold	122,980	–	–	2.9%	11
2023 Q3	$3.89M	Hold	122,980	–	–	3.84%	8
2023 Q2	$3.18M	Hold	122,980	–	–	3.58%	10
2023 Q1	$2.95M	Hold	122,980	–	–	4%	9
2022 Q4	$2.4M	Hold	122,980	–	–	3.25%	9
2022 Q3	$2.58M	Hold	122,980	–	–	3.84%	8
2022 Q2	$2.39M	Hold	122,980	–	–	3.15%	10
2022 Q1	$2.71M	Hold	122,980	–	–	3.4%	10
2021 Q4	$1.96M	Buy	+122,980	New	+$1.91M	2.39%	13

Other funds holding MIRM

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Highlander Partners's MIRM Position: Q1 2026 in Review

Highlander Partners held its Mirum Pharmaceuticals (MIRM) position steady in Q1 2026 at 122,980 shares worth $11.4M. The position accounts for 4.45% of the portfolio, ranked #7.

Highlander Partners first reported a position in MIRM in Q4 2021 and has held it in 18 quarters since. 311 funds tracked by Wall St. Rank hold MIRM as of Q1 2026.

Highlander Partners held 122,980 shares of Mirum Pharmaceuticals worth $11.4M as of Q1 2026.
Highlander Partners left its Mirum Pharmaceuticals share count unchanged in Q1 2026.
Mirum Pharmaceuticals made up 4.45% of Highlander Partners's portfolio in Q1 2026, its #7 holding.
Highlander Partners first reported a position in Mirum Pharmaceuticals in Q4 2021 and has held it in 18 quarters since.
311 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q1 2026.

Based on Highlander Partners's 13F filing for Q1 2026, filed 14 Apr 2026.